Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanobodies to multiple spike variants and inhalation of nanobody-containing aerosols neutralize SARS-CoV-2 in cell culture and hamsters
Metin Aksu, Priya Kumar, Thomas Güttler, et al.
Antiviral Research (2023) Vol. 221, pp. 105778-105778
Open Access | Times Cited: 12

Showing 12 citing articles:

Therapeutic nanobodies against SARS-CoV-2 and other pathogenic human coronaviruses
Yang Yang, Fang Li, Lanying Du
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 9
Aptamers and Nanobodies as New Bioprobes for SARS-CoV-2 Diagnostic and Therapeutic System Applications
Ki Sung Park, Tae-In Park, Jae Eon Lee, et al.
Biosensors (2024) Vol. 14, Iss. 3, pp. 146-146
Open Access | Times Cited: 6
Immunobiology of COVID-19: Mechanistic and therapeutic insights from animal models
Hong‐Yi Zheng, Tian‐Zhang Song, Yong‐Tang Zheng
动物学研究 (2024) Vol. 45, Iss. 4, pp. 747-766
Open Access | Times Cited: 4
The Use of Heterologous Antigens for Biopanning Enables the Selection of Broadly Neutralizing Nanobodies Against SARS-CoV-2
V. S. Aripov, Anna V. Zaykovskaya, Ludmila V. Mechetina, et al.
Antibodies (2025) Vol. 14, Iss. 1, pp. 23-23
Open Access
Nanoscale warriors against viral invaders: a comprehensive review of Nanobodies as potential antiviral therapeutics
Vaishali Verma, N. D. Sinha, A. Raja
mAbs (2025) Vol. 17, Iss. 1
Open Access
Nanobodies: from high-throughput identification to therapeutic development
Peter C. Fridy, Michael P. Rout, Natalia E. Ketaren
Molecular & Cellular Proteomics (2024), pp. 100865-100865
Open Access | Times Cited: 3
Inhibitors of dihydroorotate dehydrogenase synergize with the broad antiviral activity of 4′-fluorouridine
Leon Schrell, Hannah L Fuchs, Antje Dickmanns, et al.
Antiviral Research (2024) Vol. 233, pp. 106046-106046
Open Access | Times Cited: 3
Next generation single-domain antibodies against respiratory zoonotic RNA viruses
Iris C. Swart, W. van Gelder, Cornelis A. M. de Haan, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 2
Targeting cytokines in psoriatic arthritis
Laura Neurath, Michael Sticherling, Georg Schett, et al.
Cytokine & Growth Factor Reviews (2024) Vol. 78, pp. 1-13
Open Access | Times Cited: 2
Respiratory delivered vaccines: Current status and perspectives in rational formulation design
Lan Wu, Wenwen Xu, Huiyang Jiang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 12, pp. 5132-5160
Open Access | Times Cited: 1
Inhibitors of dihydroorotate dehydrogenase synergize with the broad antiviral activity of 4′-fluorouridine
Leon Schrell, Hannah L Fuchs, Antje Dickmanns, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
A breath of fresh air: inhaled antibodies to combat respiratory infectious diseases - a clinical trial overview
Noémie Alphonse, Thomas Sécher, Nathalie Heuzé-Vourc’h
Expert Opinion on Drug Delivery (2024)
Closed Access
Page 1

Scroll to top